Fig. 4From: Identifying frailty in trials: an analysis of individual participant data from trials of novel pharmacological interventionsRandom-effects meta-analysis of incidence rate ratio of serious adverse events per 0.1 point increase in frailty index. (a) Type 2 diabetes trials. (b) Rheumatoid arthritis trials. (c) COPD trialsBack to article page